Primary |
Major Depression |
21.4% |
Depression |
17.9% |
Product Used For Unknown Indication |
17.9% |
Cataplexy |
7.1% |
Antidepressant Therapy |
3.6% |
Attention Deficit/hyperactivity Disorder |
3.6% |
Bladder Disorder |
3.6% |
Divorced |
3.6% |
Drug Abuser |
3.6% |
Hypertension |
3.6% |
Incontinence |
3.6% |
Migraine |
3.6% |
Narcolepsy |
3.6% |
Urinary Incontinence |
3.6% |
|
Cataract |
5.3% |
Diabetic Retinopathy |
5.3% |
Fatigue |
5.3% |
Floppy Iris Syndrome |
5.3% |
Gun Shot Wound |
5.3% |
Hepatic Steatosis |
5.3% |
Hyperhidrosis |
5.3% |
Intracranial Aneurysm |
5.3% |
Medication Error |
5.3% |
Multiple Drug Overdose |
5.3% |
Neurotoxicity |
5.3% |
Psychotic Disorder |
5.3% |
Rib Fracture |
5.3% |
Self Injurious Behaviour |
5.3% |
Somnambulism |
5.3% |
Somnolence |
5.3% |
Therapeutic Response Unexpected With Drug Substitution |
5.3% |
Thinking Abnormal |
5.3% |
White Blood Cell Count Increased |
5.3% |
|
Secondary |
Product Used For Unknown Indication |
40.7% |
Major Depression |
22.2% |
Paranoia |
7.4% |
Anxiety |
3.7% |
Depression |
3.7% |
Enuresis |
3.7% |
Hypertension |
3.7% |
Hypertonic Bladder |
3.7% |
Nausea |
3.7% |
Pneumonia |
3.7% |
Sleep Disorder |
3.7% |
|
Completed Suicide |
20.0% |
Serotonin Syndrome |
20.0% |
Agitation |
10.0% |
Drug Ineffective |
10.0% |
Ileus Paralytic |
10.0% |
Neurotoxicity |
10.0% |
No Adverse Event |
10.0% |
Paraesthesia Oral |
10.0% |
|
Concomitant |
Product Used For Unknown Indication |
32.0% |
Hypertension |
12.1% |
Depression |
10.1% |
Pain |
4.0% |
Anxiety |
3.8% |
Osteoporosis |
3.8% |
Premedication |
3.3% |
Gastric Ulcer |
3.0% |
Migraine |
3.0% |
Multiple Sclerosis |
3.0% |
Acute Coronary Syndrome |
2.8% |
Vitamin Supplementation |
2.8% |
Acute Myeloid Leukaemia |
2.5% |
Medical Diet |
2.5% |
Bipolar Disorder |
2.0% |
Insomnia |
2.0% |
Psoriasis |
2.0% |
Diabetes Mellitus |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Hiv Infection |
1.8% |
|
Type 2 Diabetes Mellitus |
16.0% |
Fall |
6.0% |
Pain |
6.0% |
Pulmonary Embolism |
6.0% |
Seborrhoeic Dermatitis |
6.0% |
Chest Pain |
4.0% |
Cleft Palate |
4.0% |
Constipation |
4.0% |
Diabetes Mellitus |
4.0% |
Fatigue |
4.0% |
Flushing |
4.0% |
Granulocytopenia |
4.0% |
Injection Site Pain |
4.0% |
Lung Neoplasm Malignant |
4.0% |
Malignant Melanoma In Situ |
4.0% |
Melanocytic Naevus |
4.0% |
No Adverse Event |
4.0% |
Off Label Use |
4.0% |
Organ Failure |
4.0% |
Pyrexia |
4.0% |
|